Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Feb 15;99(4):732–736. doi: 10.1172/JCI119218

Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein.

Z Q Huang 1, P W Sanders 1
PMCID: PMC507857  PMID: 9045877

Abstract

Cast nephropathy is a severe complication of multiple myeloma. Binding of filtered monoclonal light chains (LC) with Tamm-Horsfall glycoprotein (THP) triggers heterotypic aggregation of these two proteins to form casts in the distal nephron of the kidney. To localize the LC binding site on THP, human THP was deglycosylated and underwent limited trypsin digestion in the presence or absence of a nephrotoxic LC known to bind THP. A 29.6-kD band was protected from trypsin digestion by the addition of LC. NH2-terminal amino acid sequence and amino acid analyses revealed this band was located between the 6th and 287th amino acid residues of THP. Six peptides located within this 29.6-kD fragment were synthesized and used as potential inhibitors of binding or aggregation of five different nephrotoxic LCs with THP. Peptide AHWSGHCCL (from amino acid 225 to 233) completely inhibited binding and aggregation of these proteins. Optimal inhibition required a cystine residue in this peptide. Truncation experiments demonstrated the entire sequence was necessary for ideal inhibition and the histidine residue explained the effects of pH on binding. These studies provided a basis for further study of LC-THP interaction and a potential approach toward the prevention of cast nephropathy.

Full Text

The Full Text of this article is available as a PDF (172.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann S., Metzger R., Bunnemann B. Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney. Histochemistry. 1990;94(5):517–523. doi: 10.1007/BF00272616. [DOI] [PubMed] [Google Scholar]
  2. Fletcher A. P., Neuberger A., Ratcliffe W. A. Tamm-Horsfall urinary glycoprotein. The chemical composition. Biochem J. 1970 Nov;120(2):417–424. doi: 10.1042/bj1200417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoyer J. R., Seiler M. W. Pathophysiology of Tamm-Horsfall protein. Kidney Int. 1979 Sep;16(3):279–289. doi: 10.1038/ki.1979.130. [DOI] [PubMed] [Google Scholar]
  4. Huang Z. Q., Kirk K. A., Connelly K. G., Sanders P. W. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J Clin Invest. 1993 Dec;92(6):2975–2983. doi: 10.1172/JCI116920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Huang Z. Q., Sanders P. W. Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy. Lab Invest. 1995 Dec;73(6):810–817. [PubMed] [Google Scholar]
  6. Pennica D., Kohr W. J., Kuang W. J., Glaister D., Aggarwal B. B., Chen E. Y., Goeddel D. V. Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science. 1987 Apr 3;236(4797):83–88. doi: 10.1126/science.3453112. [DOI] [PubMed] [Google Scholar]
  7. Sanders P. W., Booker B. B., Bishop J. B., Cheung H. C. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest. 1990 Feb;85(2):570–576. doi: 10.1172/JCI114474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sanders P. W., Booker B. B. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest. 1992 Feb;89(2):630–639. doi: 10.1172/JCI115629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sanders P. W., Herrera G. A., Galla J. H. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int. 1987 Dec;32(6):851–861. doi: 10.1038/ki.1987.286. [DOI] [PubMed] [Google Scholar]
  10. Start D. A., Silva F. G., Davis L. D., D'Agati V., Pirani C. L. Myeloma cast nephropathy: immunohistochemical and lectin studies. Mod Pathol. 1988 Sep;1(5):336–347. [PubMed] [Google Scholar]
  11. TAMM I., HORSFALL F. L., Jr Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med. 1950 May;74(1):106–108. [PubMed] [Google Scholar]
  12. Weigent D. A., Clarke B. L., Blalock J. E. Peptide design using a genetically patterned binary code: growth hormone-releasing hormone as a model. Immunomethods. 1994 Oct;5(2):91–97. doi: 10.1006/immu.1994.1042. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES